Step therapy is when Medicare Part D plans ask beneficiaries to try a more affordable drug before approving higher-cost prescriptions. In Medicare, Part D covers general prescription drugs, whereas ...

Step therapy occurs when your insurer requires you to use medication alternatives before another, possibly more expensive, treatment option. Depending on specific factors, you can work with your ...

For people with lupus, their relationship with their healthcare team is one of the most important aspects of managing their life with lupus. Step therapy imposes on that relationship in pursuit of ...

The Massachusetts House passed a bill which aims to curb the use of step therapy by health insurers. Drugs that are designated with a “step therapy” condition of reimbursement are only paid for by ...

Step therapy is a process your health insurance provider may require before it will cover certain drugs. Many insurance providers require step therapy for Mounjaro (a drug prescribed for type 2 ...

Even when doctors prescribe a medication, some insurance companies require you to try lower-cost drugs first, which could delay your ability to get the treatment you need. Samantha Rynearson was 21 ...

New law limits methods health insurers and PBMs can use to delay and discourage access to medically necessary treatments. ALBANY, NY / ACCESSWIRE / December 23, 2024 / New York Gov. Kathy Hochul ...

The frequency with which 7 of the largest Medicare Advantage plans impose step therapy protocols in their Part B drug coverage decisions varies substantially. Objectives: First, to examine 7 large ...

In this episode of The Expert Series, we talk with Health Education Specialist and Manager Ashley Holden about Step Therapy, access to medications and how it affects people with lupus.

Insurers limit the use of certain prescription drugs by requiring step therapy—that is, by allowing access only after alternatives have been tried and have failed. Using data from seventeen of the ...

Panelists discuss how step-therapy for immunoglobulin A (IgA) nephropathy is evolving toward a more personalized approach, starting with optimized supportive care before progressing to targeted ...